Work

Circulating tumor DNA (ctDNA) monitoring in the assessment and prediction of the efficacy of PARP inhibitors (PARPi).

Year: 2025
Type: article
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: closed
OpenAlex ID: W4407678499
FWCI: 0.373
Cites:
Cited by: 1
Related to: 10